Literature DB >> 6521358

Cardiovascular and adrenal sensitivity to angiotensin II in essential hypertension.

G Wambach, U Meiners, G Bönner, A Konrads, A Helber.   

Abstract

Regulation of aldosterone secretion by sodium chloride is impaired in a group of essential hypertensives: high-salt diet fails to suppress aldosterone in these patients despite low renin values. The mechanism of this impaired regulation of aldosterone has not been clarified so far. We tested the sensitivity of aldosterone secretion and blood pressure to A II in 20 normotensive controls (aged 20-60, MAP 92 +/- 3 mm Hg), in ten normotensives with one or two parents with hypertension, and in 21 patients with essential hypertension (aged 17-65, MAP 119 +/- 4 mm Hg). After a period of 6 days on high-salt intake (300-320 mEq Na+/day), A II (0.1, 0.5, 1.0 and 2.0 ng/kg/min) was infused, each concentration for 30 min. According to aldosterone excretion during sodium loading, patients were divided into group A with complete suppression (n = 12, aldosterone excretion 3.6 +/- 0.4 microgram/day) and in group B with insufficient suppression (n = 9, aldosterone excretion 15.5 +/- 2.3 micrograms/day). Despite similarly low plasma renins, rise of serum aldosterone levels during A II infusion was significantly higher in group B patients than in group A patients and normotensive controls. Rise in mean arterial blood pressure, however, brought about by graded A II infusion was similar in both groups of hypertensives and in normotensive controls. The results demonstrate an increased adrenal sensitivity to A II in a subgroup of essential hypertensives only. A similar adrenal hypersensitivity to A II found by others in patients with hyperaldosteronism due to adrenal hyperplasia supports the hypothesis that the same mechanism underlies both disorders.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6521358     DOI: 10.1007/bf01782465

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  15 in total

1.  [Aldosterone excretion and plasma renin activity in patients with essential hypertension and with primary aldosteronism (author's transl)].

Authors:  A Helber; K A Meurer; E Rosskamp; G Wambach; H A Dickmans; W Kaufmann
Journal:  Klin Wochenschr       Date:  1974-10-15

2.  [Radioimmunoassay for urinary aldosterone. Aldosterone excretion in essential hypertensives (author's transl)].

Authors:  A Helber; W Kaufmann
Journal:  Klin Wochenschr       Date:  1973-12-01

3.  Effect of age on plasma aldosterone response to exogenous angiotensin II in normotensive subjects.

Authors:  R Takeda; S Morimoto; K Uchida; I Miyamori; T Hashiba
Journal:  Acta Endocrinol (Copenh)       Date:  1980-08

4.  Evidence for a subgroup of essential hypertensives with non-suppressible excretion of aldosterone during sodium loading.

Authors:  A Helber; G Wambach; W Hummerich; G Bönner; K A Meurer; W Kaufmann
Journal:  Klin Wochenschr       Date:  1980-05-02

5.  Enhanced adrenal responsiveness to angiotensin II in patients with low renin essential hypertension.

Authors:  A D Marks; D B Marks; T M Kanefsky; V E Adlin; B J Channick
Journal:  J Clin Endocrinol Metab       Date:  1979-02       Impact factor: 5.958

6.  Increased adrenal sensitivity to angiotensin II in low-renin essential hypertension.

Authors:  M Wisgerhof; R D Brown
Journal:  J Clin Invest       Date:  1978-06       Impact factor: 14.808

7.  Enhanced aldosterone response to angiotensin II in human hypertension.

Authors:  E S Kisch; R G Dluhy; G H Williams
Journal:  Circ Res       Date:  1976-06       Impact factor: 17.367

8.  Parallel adrenal and renal abnormalities in young patients with essential hypertension.

Authors:  G H Williams; M L Tuck; J M Sullivan; R G Dluhy; N K Hollenberg
Journal:  Am J Med       Date:  1982-06       Impact factor: 4.965

9.  Converting-enzyme inhibition corrects the altered adrenal response to angiotensin II in essential hypertension.

Authors:  T Taylor; T J Moore; N K Hollenberg; G H Williams
Journal:  Hypertension       Date:  1984 Jan-Feb       Impact factor: 10.190

10.  The plasma aldosterone response to angiotensin II infusion in aldosterone-producing adenoma and idiopathic hyperaldosteronism.

Authors:  M Wisgerhof; R D Brown; M J Hogan; P C Carpenter; A J Edis
Journal:  J Clin Endocrinol Metab       Date:  1981-02       Impact factor: 5.958

View more
  2 in total

Review 1.  Progress in primary aldosteronism: present challenges and perspectives.

Authors:  C E Gomez-Sanchez; G P Rossi; F Fallo; M Mannelli
Journal:  Horm Metab Res       Date:  2010-01-20       Impact factor: 2.936

2.  Tissue Transglutaminase-Mediated AT1 Receptor Sensitization Underlies Pro-inflammatory Cytokine LIGHT-Induced Hypertension.

Authors:  Chen Liu; Renna Luo; Wei Wang; Zhangzhe Peng; Gail V W Johnson; Rodney E Kellems; Yang Xia
Journal:  Am J Hypertens       Date:  2019-04-22       Impact factor: 2.689

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.